As of 2024-12-15, the Relative Valuation of Novavax Inc (NVAX) is (44.46) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.11 USD, the upside of Novavax Inc based on Relative Valuation is -588.0%.
The range of the Relative Valuation is (39.02) - (56.13) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.9x - 31.6x | 26.4x |
| Forward P/E multiples | 21.1x - 31.6x | 23.6x |
| Fair Price | (39.02) - (56.13) | (44.46) |
| Upside | -528.3% - -716.1% | -588.0% |
| Date | P/E |
| 2024-12-13 | -5.12 |
| 2024-12-12 | -5.07 |
| 2024-12-11 | -4.96 |
| 2024-12-10 | -4.93 |
| 2024-12-09 | -5.10 |
| 2024-12-06 | -5.03 |
| 2024-12-05 | -4.67 |
| 2024-12-04 | -4.67 |
| 2024-12-03 | -4.73 |
| 2024-12-02 | -4.93 |
| 2024-11-29 | -4.90 |
| 2024-11-27 | -4.85 |
| 2024-11-26 | -4.92 |
| 2024-11-25 | -5.24 |
| 2024-11-22 | -4.76 |
| 2024-11-21 | -4.52 |
| 2024-11-20 | -4.53 |
| 2024-11-19 | -4.50 |
| 2024-11-18 | -4.40 |
| 2024-11-15 | -4.12 |
| 2024-11-14 | -4.06 |
| 2024-11-13 | -4.37 |
| 2024-11-12 | -4.76 |
| 2024-11-11 | -5.07 |
| 2024-11-08 | -5.01 |
| 2024-11-07 | -5.16 |
| 2024-11-06 | -5.04 |
| 2024-11-05 | -5.31 |
| 2024-11-04 | -5.13 |
| 2024-11-01 | -5.26 |
| 2024-10-31 | -5.40 |
| 2024-10-30 | -5.53 |
| 2024-10-29 | -5.66 |
| 2024-10-28 | -5.76 |
| 2024-10-25 | -5.48 |
| 2024-10-24 | -5.58 |
| 2024-10-23 | -5.62 |
| 2024-10-22 | -5.69 |
| 2024-10-21 | -5.70 |
| 2024-10-18 | -5.72 |
| 2024-10-17 | -5.82 |
| 2024-10-16 | -5.71 |
| 2024-10-15 | -7.09 |
| 2024-10-14 | -7.10 |
| 2024-10-11 | -7.05 |
| 2024-10-10 | -7.26 |
| 2024-10-09 | -7.13 |
| 2024-10-08 | -7.33 |
| 2024-10-07 | -7.32 |
| 2024-10-04 | -7.65 |